Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Gynecol Oncol. 2016 Jun 1;142(2):261–266. doi: 10.1016/j.ygyno.2016.05.024

Table 4.

Five-year survival rates by stage and sub-stage

Five-year survival rate
Stage
I 98.3 (96.8–99.1)
IA 98.7 (96.7–99.4)
IB–IC 97.1 (91.0–99.1)
INOS 98.4 (89.4–99.8)
II 93.2 (82.8–97.4)
III 82.7 (74.3–88.5)
IV 72.0 (50.1–85.5)
Unknown 94.3 (85.4–97.8)

83 patients with missing vital status or follow-up time were excluded.